New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation
Duvoisin, R.C.
Neurology 39(11 Suppl 2: 4-6
1989
ISSN/ISBN: 0028-3878 PMID: 2573862 Document Number: 332473
Document emailed within 1 workday
Related Documents
1997: Therapy of Parkinson disease. Continuous physiologic dopaminergic stimulation with carbergoline Der Nervenarzt 68(3 Suppl Therapie D): 1-4Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Wahab, A.; Khan, G.M.; Akhlaq, M.; Khan, N.R.; Hussain, A.; Khan, M.F.; Khan, H. 2011: Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism Die Pharmazie 66(9): 677-683
Mark, M.H.; Sage, J.I. 1989: Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease Annals of Clinical and Laboratory Science 19(2): 101-106
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
Dempski, R.E.; Scholtz, E.C.; Oberholtzer, E.R.; Yeh, K.C. 1989: Pharmaceutical design and development of a Sinemet controlled-release formulation Neurology 39(11 Suppl 2: 20-24
George, N.; Sujatha, C.H.; Kalyanasundaram, M. 1987: Controlled release formulation of mosquito larvicide with biodegradable ingredients Indian Journal of Medical Research 86: 728-732
Muenter, M.D. 1970: Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease Neurology 20(12 Suppl): 6-13
Korczyn, A.D. 2003: Dopaminergic drugs in development for Parkinson's disease Advances in Neurology 91: 267-271
Franc, Aš.; Dvořáčková, Křina.; Muselík, J.; Zvaková, M.; Slováková, Víra.; Vetchý, D.; Sabadková, D.; Neumann, D.; Goněc, R. 2014: Formulation of cores for the controlled release of glucose for prevention of hypoglycemia in diabetes patients Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 63(5): 206-212
Zabek, M.; Mazurowski, W.; Dymecki, J.; Stelmachów, J.; Gawur, B.; Trautsolt, W.; Zawada, E. 1992: Transplantation of fetal dopaminergic cells in Parkinson disease Neurologia i Neurochirurgia Polska Suppl 1: 13-19
Friedman, D.; Pathak, Y.V.; Benita, S. 1989: Micronized emulsion for controlled release of physostigmine after oral administration. Part I. Formulation design Drug Design and Delivery 4(2): 135-142
Agnoli, A.; Stocchi, F.; Carta, A.; Antonini, A.; Bragoni, M.; Ruggieri, S.A. 1988: Continuous dopaminergic stimulation in the management of complicated Parkinson's disease Mount Sinai Journal of Medicine new York 55(1): 62-66
Schoenberg, B.S. 1987: Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation Advances in Neurology 45: 277-283
Ishida, Y. 2005: Psychiatric symptoms of Parkinson's disease--an overview from the studies on dopaminergic nerves Seishin Shinkeigaku Zasshi 107(3): 290-293
Clough, C.G.; Bergmann, K.J.; Yahr, M.D. 1984: Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration Advances in Neurology 40: 131-140
Hirsch, E.C. 2000: Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment Annals of Neurology 47(4 Suppl 1): S115
Prabhakar, S.; Syal, P.; Srivastava, T. 2000: P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs Neurology India 48(3): 239-242
Seng, C.Moh.; Setha, T.; Nealon, J.; Socheat, D.; Nathan, M.B. 2008: Six months of Aedes aegypti control with a novel controlled-release formulation of pyriproxyfen in domestic water storage containers in Cambodia Southeast Asian Journal of Tropical Medicine and Public Health 39(5): 822-826
Melamed, E.; Hefti, F.; Wurtman, R.J. 1982: Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model Israel Journal of Medical Sciences 18(1): 159-163